Clearing a path for the next wave in cancer treatment

Therapeutic cancer vaccines stand to revolutionize patient care by harnessing our immune system's natural ability to recognize and safely destroy cancer cells.

The Cancer Vaccine Acceleration Fund (CVAF) is a new CRI venture philanthropy program dedicated to unlocking the full promise of these treatments sooner by providing biotech companies with funding and other valuable clinical trials resources in support of early stage clinical trials.

Contact:
Adam Kolom, Director
Cancer Vaccine Acceleration Fund
akolom@cancerresearch.org